Simon Cottle

Simon is a Founding Partner at Stanley Capital. Since founding SC, Simon has originated and led the Noden Pharma and Essential deals.Prior to this, Simon gained lead investor experience as managing director and investment committee member at Ardian and director at Hg Capital. At Ardian and Hg Capital Simon led or co-led deals into Parts […]

Patrick Hargutt

Patrick is a Founding Partner at Stanley Capital. He co-led Stanley’s investment into Noden. Patrick is a private equity and special situations investor with a strong track record across both equity and debt transactions. Prior to Stanley Capital, Patrick was an investor at Centerbridge Partners and Monarch Alternative Capital. He began his career as an […]

James Brooks

James is a Founding Partner at Stanley Capital and co-led Stanley’s investment into Noden Pharma Until September 2021 he was on the leadership team of Shell’s R&ES division, responsible for strategy and investment decision making for platforms across power, e-mobility, hydrogen, carbon offsets and venture investing From 2016 to 2020, James co-led the rapid growth […]

Matt Harrison

Matt is a Partner at Stanley Capital and Chief Financial Officer (CFO). He has over 20 years of private equity experience mainly in CFO and chief operating officer (COO) positions.​ Prior to joining Stanley, Matt was CFO of Candover Investments plc and co-founder and COO of Arle Capital​. He co-led the buyout of Arle from Candover in a public market transaction, eventually selling Arle in 2017. Most recently […]